Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil J Freireich

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantationApostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGelHatice Duzkale, Lance C Pagliaro, Michael G Rosenblum, et al.
Cancer|February 6, 2003
Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosisHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
Blood|February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patientsHatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Blood|February 25, 2006
Eradication of minimal residual disease in hairy cell leukemiaFarhad Ravandi, Jeffrey L Jorgensen, Susan M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer CenterApostolia M Tsimberidou, Sijin Wen, Susan O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up resultsHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Cancer|April 13, 2018
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000Hagop M Kantarjian, Courtney D DiNardo, Graciela M Nogueras-Gonzalez, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantationApostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGelHatice Duzkale, Lance C Pagliaro, Michael G Rosenblum, et al.
Cancer|February 6, 2003
Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosisHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
Blood|February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patientsHatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Blood|February 25, 2006
Eradication of minimal residual disease in hairy cell leukemiaFarhad Ravandi, Jeffrey L Jorgensen, Susan M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer CenterApostolia M Tsimberidou, Sijin Wen, Susan O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up resultsHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Cancer|April 13, 2018
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000Hagop M Kantarjian, Courtney D DiNardo, Graciela M Nogueras-Gonzalez, et al.
Pageof 6